Results 181 to 190 of about 120,013 (263)

Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu   +10 more
wiley   +1 more source

Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam   +3 more
wiley   +1 more source

Developmental Hypoxia Increases Susceptibility to Cardiac Ventricular Arrhythmias in Adult Offspring

open access: yes
Lock MC   +13 more
europepmc   +1 more source

Conduction System Pacing With Defibrillator Therapy in a Patient With Heart Failure and Ventricular Arrhythmias After Mitral Valve Replacement. [PDF]

open access: yesCureus
Szulik M   +8 more
europepmc   +1 more source

Controlling Nutritional Status score as a predictor of ventricular arrhythmias in patients with advanced heart failure. [PDF]

open access: yesESC Heart Fail
Ono Y   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy